glucose

Cancers have many strategies for avoiding attacks from the immune system. But the more scientists are able to understand about them, the more effectively they will be able to use the immune system to fight cancer. To that end, researchers at Washington University School of Medicine in St. Louis have identified a new strategy.

Working in mice, researchers at Washington University School of Medicine in St. Louis led by Brian N. Finck, PhD (left), and Kyle S. McCommis, PhD, showed they could reduce glucose production in the liver and lower blood sugar levels. Their approach — shutting down a liver protein involved in making glucose — may help treat type 2 diabetes.

Researchers at Washington University School of Medicine in St. Louis have found that a popular artificial sweetener can modify how the body handles sugar. They analyzed the sweetener sucralose in 17 severely obese people and found it can influence how the body reacts to glucose.

Researchers at Washington University School of Medicine in St. Louis, led by Philip Stahl, PhD, professor of cell biology and physiology have identified a potent regulator of sensitivity to insulin, the hormone that controls blood sugar levels. The new findings may help scientists find better treatments for type 2 diabetes, obesity and other health problems caused by the body’s inability to properly regulate blood sugar.

Organisms from yeast to rodents to humans all benefit from cutting calories. In less complex organisms, restricting calories can double or even triple lifespan. But researchers at Washington University School of Medicine and two other centers report in the journal Science that they are less interested in calorie restriction for longer life than for its ability to promote good health throughout life.  

Islets isolated from a rat pancreasDiabetes researchers hoping to enlist the help of a protein targeted by cancer therapies have gained an important new insight into how the protein, known as mTOR, works in the pancreas. Ironically, diabetes researchers want to promote the capability of mTOR that oncologists want to shut down: its ability to cause cells to reproduce by dividing into copies of themselves.

Islets isolated from a rat pancreasDiabetes researchers hoping to enlist the help of a protein targeted by cancer therapies have gained an important new insight into how the protein, known as mTOR, works in the pancreas. Ironically, diabetes researchers are hoping to promote the capability of mTOR that oncologists want to shut down: its ability to cause cells to reproduce by dividing into copies of themselves. That capacity can be deadly in tumors, but diabetes researchers want to use mTOR’s ability to make cells divide to maintain enough insulin-making beta cells in the pancreas to prevent diabetes. More…